Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
L-type calcium channels are voltage-gated calcium channels that mediate calcium influx into excitable cells upon membrane depolarization. They are crucial for muscle contraction, hormone secretion, neuronal signaling, and other calcium-dependent processes. They are composed of a pore-forming α1 subunit and auxiliary subunits (β, γ, α2δ). There are four main α1 subunit isoforms (CaV1.1, CaV1.2, CaV1.3, CaV1.4) encoded by CACNA1S, CACNA1C, CACNA1D, and CACNA1F genes, respectively, each with distinct tissue distributions and physiological roles. L-type calcium channels are important drug targets, particularly for antihypertensive agents like dihydropyridines.
Blockage of calcium influx through L-type calcium channels
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on L-type Calcium Channel Protein (LTCC).